Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Sarcoma × Dacarbazine × Clear all

Phase

Status

Completed 7 Recruiting 3 Terminated 2 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hodgkin Disease 8 Melanoma 3 Neoplasms 2 Sarcoma 1 Lung Neoplasms 1 Kidney Neoplasms 1 Colonic Neoplasms 1 Breast Neoplasms 1

Interventions

Nivolumab 10 pembrolizumab 9 Radiotherapy 9 Magnetic Resonance Spectroscopy 9 Specimen Handling 8 Doxorubicin 8 Cyclophosphamide 7 Biopsy 7 X-Rays 6 Ipilimumab 6 Phantoms, Imaging 5 talimogene laherparepvec 4 Radiation 4 Nuclear Medicine Department, Hospital 4 selpercatinib 3 pazopanib 3 palbociclib 3 cabozantinib 3 Standard of Care 3 Sirolimus 3 Ifosfamide 3 Bevacizumab 3 ulixertinib 2 tipifarnib 2 tazemetostat 2 olaparib 2 liposomal doxorubicin 2 larotrectinib 2 ivosidenib 2 fludarabine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04733183 2025-01-27

FLASH

Philogen S.p.A.

Phase 2 Active not recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡